ZIVO Bioscience, Inc. (ZIVO)
$0.7297
-0.00 (-0.01%)
Rating:
Recommendation:
-
| Symbol | ZIVO |
|---|---|
| Price | $0.7297 |
| Beta | 0.271 |
| Volume Avg. | 0.02M |
| Market Cap | 1.328M |
| Shares () | - |
| 52 Week Range | 0.48-22.5 |
| 1y Target Est | - |
| DCF Unlevered | ZIVO DCF -> | |
|---|---|---|
| DCF Levered | ZIVO LDCF -> | |
| ROE | 568.13% | Strong Buy |
| ROA | -404.82% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | -137.30% | Sell |
| P/E | -0.14 | Neutral |
| P/B | -1.16 | Sell |
Latest ZIVO news
About
Download (Excel)ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan.